Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00659737 · ClinicalTrials.gov registry record · NA
Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
A NA study, sponsored by Drexel University College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT00659737 is a NA study that has completed, run by Drexel University College of Medicine. The registered enrollment target is 115 participants.
The verdict
NCT00659737, a NA study, has completed, sponsored by Drexel University College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
Recent evidence suggests multiple drug therapy is superior to single agents. The study compares the incidence of nausea, vomiting, need for rescue medication, prolonged PACU time, and unplanned hospital admission in patients with high risk for PONV treated with oral aprepitant with or without transdermal scopolamine preoperatively.
Interventions
- DRUG Scopolamine
- DRUG Aprepitant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00659737
The ClinicalTrials.gov registry entry for NCT00659737 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University College of Medicine, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Scopolamine is the first listed.
NCT00659737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00659737 about?
NCT00659737 is a clinical study titled "Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting". Recent evidence suggests multiple drug therapy is superior to single agents. The study compares the incidence of nausea, vomiting, need for rescue medication, prolonged PACU time, and unplanned hospital admission in patients with high risk for PONV treated with oral aprepitant with or without transd...
What is the current status of trial NCT00659737?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2008-04. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00659737?
The interventions under investigation include: Scopolamine (DRUG), Aprepitant (DRUG).
Who is sponsoring clinical trial NCT00659737?
This trial is sponsored by Drexel University College of Medicine, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.